blinatumomab
astellas,amgen
['leukemia', 'leusm']
#ash22 #leusm litzow: median os nr w blin vs 71.4mo wo blin (hr 0.42, p=0.003). median rfs nr w blin vs 22.4mo wo blin (hr 0.46 p=0.004). for mrd+ only small n didn t get blin, comparison not sig. this study will make blin consolidation new soc regardless of mrd resp to chemo! 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)